1. Home
  2. OPGN

OPGN

OpGen Inc.

Logo OpGen Inc.

Health Care

Medical Specialities

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

Founded: N/A Country:
United States
United States
Employees: N/A City: ROCKVILLE
Market Cap: 8.4M IPO Year: 2015
Target Price: N/A AVG Volume (30 days): 1.8M
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -6.51 EPS Growth: N/A
52 Week Low/High: $0.17 - $3.84 Next Earning Date: 05-13-2024
Revenue: $3,070,233 Revenue Growth: -7.28%
Revenue Growth (this year): 1.98% Revenue Growth (next year): -0.26%

Share on Social Networks: